Quantitative Insights, Inc.: FDA clearances and approvals

Quantitative Insights, Inc. has 1 FDA 510(k) clearance (first 2017, latest 2017), plus 1 De Novo decision, across 2 product codes in 1 review panel. Median 510(k) review time: 114 days.

510(k) clearances per year

YearClearancesMedian review days
20171114
20180—
20190—
20200—
20210—
20220—
20230—
20240—
20250—
20260—

Review time against the same product codes

Since 2017, Quantitative Insights, Inc.'s cleared 510(k)s took a median 114 days from FDA receipt to decision. All cleared 510(k)s in the same product codes over the same years took a median 127 days.

Top product codes

Product codeDeviceSubmissions510(k) clearances
LLZSystem, Image Processing, Radiological11
POKComputer-Assisted Diagnostic Software For Lesions Suspicious For Cancer10

Review panels

Most recent Quantitative Insights, Inc. 510(k) clearances

510(k)DeviceProduct codeDecision dateReview days
K170195QuantXLLZ2017-05-17114

PMA and De Novo decisions

NumberPathwayDeviceDecision date
DEN170022De NovoComputer-Assisted Diagnostic Software For Lesions Suspicious For Cancer2017-07-19

Recalls

openFDA lists no recalls under a recalling firm named Quantitative Insights, Inc..

Recalling firms are matched to this company by name only (same normalization as the applicant), so related entities that recall under another name are not counted.

Frequently asked questions

How many FDA 510(k) clearances does Quantitative Insights, Inc. have?

Quantitative Insights, Inc. has 1 FDA 510(k) clearance (first 2017, latest 2017), plus 1 De Novo decision, across 2 product codes in 1 review panel.

How long does FDA take to clear Quantitative Insights, Inc.'s 510(k)s?

The median time from FDA receipt to decision across Quantitative Insights, Inc.'s cleared 510(k)s is 114 days.

What devices does Quantitative Insights, Inc. make?

Its most frequent FDA product codes are LLZ (System, Image Processing, Radiological, 1); POK (Computer-Assisted Diagnostic Software For Lesions Suspicious For Cancer, 1).

Has Quantitative Insights, Inc. had device recalls?

openFDA lists no recalls under a recalling firm name matching Quantitative Insights, Inc. Related entities may recall under other names.

Next steps

Data from openFDA (510(k), PMA, De Novo, device recalls), ClinicalTrials.gov and SEC company tickers. Companies are grouped by FDA applicant name with punctuation and legal suffixes removed. Review days run from FDA receipt to decision. Not regulatory advice.

All FDA device companies · FDA product code lookup